• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

3-D mammography clears FDA

Article

Tuned-aperture CT (TACT) has passed FDA review. The 3-D mammography system promises to better visualize tumors in dense parts of the breast or other regions often obscured by overlying tissues. The technology, which was licensed by Wake Forest University

Tuned-aperture CT (TACT) has passed FDA review. The 3-D mammography system promises to better visualize tumors in dense parts of the breast or other regions often obscured by overlying tissues. The technology, which was licensed by Wake Forest University School of Medicine to Instrumentarium Imaging, is an integral part of the Delta 32 TACT 3-D breast imaging system, which will be available exclusively on Instrumentarium Imaging’s Diamond Breast Care System. Using TACT, Instrumentarium has also developed a dental imaging system and a computer program called CliniView.

Related Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.